Document is current
Any future updates will be listed below
-
Authors
Lehmann, Anja I. https://orcid.org/0000-0002-0108-4803
Rodgers, Stephanie
Kamm, Christian P.
Mettler, Mathias
Steinemann, Nina
Ajdacic-Gross, Vladeta
Kaufmann, Marco
Kesselring, Jürg
Calabrese, Pasquale
Salmen, Anke
Gobbi, Claudio
Zecca, Chiara
Bauer, Georg F.
von Wyl, Viktor
-
Funding
Funding for this research was provided by:
Schweizerische Multiple Sklerose Gesellschaft
- License Information
-
More Information
Article History
Received: 22 March 2020
Revised: 28 May 2020
Accepted: 3 June 2020
First Online: 11 June 2020
Compliance with ethical standards
:
: The author(s) disclose receipt of the following financial support for the research, authorship, and/or publication of this article: Kamm CP has received honoraria for lectures as well as research support from Biogen, Novartis, Almirall, Bayer Schweiz AG, Teva, Merck, Sanofi Genzyme, Roche, Eli Lilly, Celgene and the Swiss MS Society (SMSG). AS received speaker honoraria and/or travel compensation for activities with Almirall Hermal GmbH, Biogen, Merck, Novartis, Roche and Sanofi Genzyme, and research support from the Swiss MS Society, not related to this work. CG: The Employer Department of Neurology, Regional Hospital Lugano (EOC), Lugano, Switzerland, receives financial support from Biogen Idec, Celgene, Sanofi, Merck Serono, Novartis Roche and Teva. The submitted work is not related to these agreements. CZ: The Employer Department of Neurology, Regional Hospital Lugano (EOC), Lugano, Switzerland, receives financial support from Biogen Idec, Celgene, Sanofi, Merck Serono, Novartis Roche and Teva. The submitted work is not related to these agreements. AIL, SR, NS, VAG, MK, JK, PC, MM, GFB and VVW declare that there is no conflict of interest.
: The authors declare that this study has been carried out in accordance with ethical standards.
